Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
Could NanoKnife be the future of prostate cancer care?
A Life-Saving Idea for Bladder Cancer Patients.
Bladder removal is life-altering. This study examines when and why some patients may not need it.
Fighting for life everywhere she goes.
Where a man is born, lives and works can influence his prostate cancer diagnosis, treatment, and survival. But which factors matter most? And what role do they all play together in how he responds to cancer treatment?
The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.
Digging into the "why" of racial disparity in kidney cancer outcomes.
Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.
Two new collaborative publications focus on treatment decisions for patients with renal masses.
Three members of Fox Chase Cancer Center’s Genitourinary Cancer Program – Elizabeth Plimack, MD, MS; Alexander Kutikov, MD, FACS; and Benjamin Miron, MD -- have gained national recognition for their work advancing the care of patients ...
As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
Evaluating the current standards of care for cystectomy yielded interesting results on when it is most appropriate.